NASDAQ:ARCT

Arcturus Stock Faces a Big 72 Hours: What Could Move ARCT Next
····

Arcturus Stock Faces a Big 72 Hours: What Could Move ARCT Next

Arcturus Therapeutics traded at $7.81 in pre-market Tuesday, up 0.5% from Monday’s close after a 1.9% drop the previous session. The company will present at the Jefferies healthcare conference June 4 and hold its annual meeting June 5. Quarterly revenue fell to $2.1 million from $29.4 million a year earlier, with cash at $213.4 million as of March 31. Investors remain focused on trial progress and cash runway.
June 2, 2026

Stock Market Today

  • British American Tobacco Shares Drop 4% Amid Lowered Volume Forecasts
    June 2, 2026, 8:38 AM EDT. British American Tobacco's (LSE:BATS) shares fell 4% following a trading update that cut 2026 cigarette volume projections from a 2% to 2.5% decline. The FTSE 100 tobacco giant, which had gained 32% over the past year, attributes the sharper volume drop to rising health concerns and tightening regulations on combustible products worldwide, particularly in emerging Asian markets. Despite the setback, the company remains optimistic about revenue growth prospects from non-combustible products, such as Vuse vapes and Velo gum, which exceeded first-half sales expectations. BAT now anticipates full-year results at the lower end of its medium-term guidance: 3%-5% revenue growth and 4%-6% adjusted operating profit growth.